| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 5, 2018Award coincides with the opening of Recursion's expansive new R&D facility
Recursion Pharmaceuticals, a biotechnology company that combines artificial intelligence (AI), experimental biology, and automation to discover and develop drugs at scale, has been awarded a 2018...
-
Jul 10, 2018
Recursion, a biotechnology company that combines artificial intelligence (AI), experimental biology, and automation to discover drugs at scale, today announced that the U.S. Food and Drug...
-
Jul 10, 2018
Recursion, a biotechnology company that combines artificial intelligence (AI), experimental biology, and automation to discover and develop drugs at scale, today announced the company has...
-
May 15, 2018
Recursion Pharmaceuticals, a biotechnology company that combines artificial intelligence (AI), experimental biology, and automation to discover drugs at scale, today announced that it has hired...
-
May 7, 2018The grant, awarded by the Bill & Melinda Gates Foundation, represents a collaborative effort between Recursion and the Winzeler Lab at UC San Diego School of Medicine to accelerate the discovery of drugs to treat malaria, and sets the stage for Recursion to further broaden its drug discovery platform into infectious disease.
Recursion Pharmaceuticals today announced the award of a $546,000 grant from the Bill & Melinda Gates Foundation to apply Recursion's AI-enabled technology to the discovery of novel drugs with the...